# Study of NMS-1116354 in Solid Tumors

> **NCT01016327** · PHASE1 · TERMINATED · sponsor: **Nerviano Medical Sciences** · enrollment: 15 (actual)

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** NMS-1116354

## Key facts

- **NCT ID:** NCT01016327
- **Lead sponsor:** Nerviano Medical Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-04
- **Primary completion:** 2011-12
- **Final completion:** 2012-09
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Discontinuation of clinical investigation with NMS-1116354
- **Last updated:** 2012-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01016327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01016327, "Study of NMS-1116354 in Solid Tumors". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01016327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*